$LTRN
Lantern Pharma Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Lantern Pharma Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is LTRN down today? It is at $0.230 (-13.70%), and our scanner flagged it 9 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment LTRN spikes, and full due diligence on LTRN — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $LTRN 9 times in the last 30 days. Create a free account to track $LTRN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
The market is closed. Here is how LTRN traded in the last session, Friday (last price and move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystPharma Reports Third Quarter 2026, from an SEC filing. Read it →Latest filingDEFA14AAdditional proxy materialNov 20, 2026 · yesterdayAcross every filing on file, supply equal to 72.2% of the tradeable float is in play - 72.2% has already been sold.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
7,339,450 new shares · Priced at $1.09/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Keyser D Jeffrey Director | Bought (open market) | +49K 0.3% of company | added 100% | 94K | $100K at $2.06 | May 12, 26 |
Schalop Lee Troy Director | Bought (open market) | +49K 0.3% of company | n/a | 49K | $100K at $2.06 | May 12, 26 |
Kreis Leslie W. Beneficial Owner (10%) | Sold (automatic/other) | -40K 0.3% of company | sold 3.6% | 1.08M | $124K at $3.09 | Jun 13, 25 |
Fletcher Aaron G.L. Beneficial Owner (10%) | Sold (automatic/other) | -40K 0.3% of company | sold 3.6% | 1.08M | $124K at $3.09 | Jun 13, 25 |
Kreis Leslie W. Beneficial Owner (10%) | Sold (automatic/other) | -61K 0.4% of company | sold 5.2% | 1.12M | $205K at $3.38 | Jun 12, 25 |
Fletcher Aaron G.L. Beneficial Owner (10%) | Sold (automatic/other) | -61K 0.4% of company | sold 5.2% | 1.12M | $205K at $3.38 | Jun 12, 25 |
Kreis Leslie W. Beneficial Owner (10%) | Sold (automatic/other) | -950 | sold 1.7% | 55K | $3K at $3.40 | Jun 11, 25 |
Fletcher Aaron G.L. Beneficial Owner (10%) | Sold (automatic/other) | -950 | sold 1.7% | 55K | $3K at $3.40 | Jun 11, 25 |
Kreis Leslie W. Beneficial Owner (10%) | Sold (automatic/other) | -16 | sold <0.1% | 55K | $54 at $3.40 | Jun 10, 25 |
Fletcher Aaron G.L. Beneficial Owner (10%) | Sold (automatic/other) | -16 | sold <0.1% | 55K | $54 at $3.40 | Jun 10, 25 |
Kreis Leslie W. Beneficial Owner (10%) | Sold (automatic/other) | -20K 0.1% of company | sold 1.7% | 1.18M | $61K at $3.03 | May 29, 25 |
Fletcher Aaron G.L. Beneficial Owner (10%) | Sold (automatic/other) | -20K 0.1% of company | sold 1.7% | 1.18M | $61K at $3.03 | May 29, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.

The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
The market is closed. Here is how LTRN traded in the last session, Friday (last price and move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
LTRN last traded at $0.230, down 13.70% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The LTRN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged LTRN 9 times in the last 30 days.
LTRN (Lantern Pharma Inc. Common Stock) trades on XNAS, with a market cap of about $4M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge LTRN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$LTRN discussion
Sign in to ask a question or join the discussion.